Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 1016-1022

  Meyers, Rebecka L ^a   Rowland, Jon R ^b   Krailo, Mark ^c,d   Chen, Zhengjia ^c,d   Katzenstein, Howard M ^e   Malogolowkin, Marcio H ^f  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

^e Children's Hospital   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Alpha fetoprotein; Hepatoblastoma; Overall survival; PRETEXT; Prognostic factors; Small cell undifferentiated histology; Stage; Surgical margin

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; VINCRISTINE;

ARTERY THROMBOSIS; ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGITIS; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIAPHRAGM INJURY; FETUS; HEPATIC ARTERY; HEPATOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; INFORMATION; LIVER DISEASE; LIVER FAILURE; MULTICENTER STUDY; ONCOLOGY; OVERALL SURVIVAL; PORTAL HYPERTENSION; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK; VARIX BLEEDING;

ALPHA-FETOPROTEINS; CHILD; HEPATOBLASTOMA; HISTOLOGY; HUMANS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 71049119486     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22088     Document Type: Article

References (25)

1. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982;50:821-826.
2. Sasaki F, Matsunaga T, Iwafuchi M, et al. Outcome of hepatoblastoma treated with JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 2002;37: 851-856. (Pubitemid 34575792)
3. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/ continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000;18:2665-2675.
4. Reynolds M, Douglass EC, Finegold M, et al. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992;27: 1080-1084.
5. Von Schweinitz D, Hecker H, Schmidt-von-Arndt G, et al. Prognostic factors and staging systems in childhood hepato-blastoma. Int J Cancer 1997;74:593-599. (Pubitemid 28037500)
6. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma: Results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000;36:1418-1425. (Pubitemid 30421147)
7. Czauderna P, Otte JB, Roebuck DJ, et al. Surgical treatment of hepatoblastoma in children. Pediatr Radiol 2006;36:187-191.
8. Plaschkes J, Vos A, Czauderma P, et al. Into the year 2000 with SIOPEL 3: Cisplatin alone or in combination for standard and high risk hepatoblastoma. Med Pediatr Oncol 1998;31:240.
9. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: Results from the first prospective trial of the International Society of Paediatric Oncology Liver Tumor Study Group (SIOPEL 1). Cancer 2002; 94:1111-1120. (Pubitemid 34150867)
10. Stringer MD. Liver tumors. Semin Pediatr Surg 2000;9:196-208.
11. Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Grou p SIOPEL-1 study. J Clin Oncol 2005;23:1245-1252.
12. Roebuck DJ, Olsen O, Pariente D. Radiological staging in children with hepatoblastoma. Pediatr Radiol 2005;36:176-182.
13. Czauderna P, Otte JB, Aronson DC, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era - Recommendations from the Childhood Liver Tumor Strategy Group of the International Society of Pediatric Oncology (SIOPEL). Eur J Cancer 2005;41:1031-1036. (Pubitemid 40602855)
14. Von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg 2006;15:14-17.
15. Von Schweinitz D. Identification of risk groups in hepatoblastoma: Another step in optimizing therapy. Eur J Cancer 2000;36:1343-1346. (Pubitemid 30421136)
16. Davies JQ, de la Hall PM, Kaschula RO, et al. Hepatoblastoma - Evolution and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg 2004;39:1321-1327.
17. Schnater JM, Kuijper CF, Zsiros J, et al. Pre-operative diagnostic biopsy and surgery in pediatric liver tumors - The Amsterdam experience. Eur J Surg Oncol 2005;31:1160-1165. (Pubitemid 41819202)
18. Tiao GM, Bobey N, Allen S, et al. The current management of hepatoblastoma: A combination of chemotherapy, conventional resection and liver transplantation. J Pediatr Surg 2005;146:204-211. (Pubitemid 40202810)
19. Brugieres L, Plaschkes J, MacKinlay G, et al. Hepatoblastoma: Microscopic residual disease after delayed surgery, prognostic implications. Med Pediatr Oncol 2000;35:177.
20. Dicken BJ, Bigam DL, Lees GM. Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg 2004;39:721-725.
21. Fuchs J, Rydzynski J, Hecker H, et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma: A report from the German cooperative liver tumor studies HB 89 and HB 94. Eur J Pediatr Surg 2002;12:255-261.
22. Towu E, Kiely E, Pierro A, et al. Outcome and complications after resection of hepatoblastoma. J Pediatr Surg 2004;39:199-202.
23. Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: A revised staging system for primary malignant tumors of childhood developed by the SIOPEL group. Pediatr Radiol 2007;37:123-132.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
25. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons; 1980.